<em>Call for Special Issue Papers:</em> Cannabinoids and the Immune System: Deadline for Manuscript Submission: December 31, 2020

Published by Michael on

Related Posts

Medical

Cannabis use in patients treated for opioid use disorder pre- and post-recreational cannabis legalization in Canada

Subst Abuse Treat Prev Policy. 2021 Apr 13;16(1):34. doi: 10.1186/s13011-021-00372-z. ABSTRACT BACKGROUND: As the legalization of recreational cannabis becomes more widespread, its impact on individuals with substance use disorders must be studied. Amidst an ongoing Read more…

Medical

Attitudes toward medical cannabis among family physicians practising in Ontario, Canada: a qualitative research study

CMAJ Open. 2021 Apr 13;9(2):E342-E348. doi: 10.9778/cmajo.20200187. Print 2021 Apr-Jun. ABSTRACT BACKGROUND: Medical cannabis has been legally available in Canada since 2001, but its benefits and harms remain uncertain. We explored attitudes toward medical cannabis Read more…

Medical

A systematic review of neuroimaging and acute cannabis exposure in age-of-risk for psychosis

Transl Psychiatry. 2021 Apr 13;11(1):217. doi: 10.1038/s41398-021-01295-w. ABSTRACT Acute exposure to cannabis has been associated with an array of cognitive alterations, increased risk for neuropsychiatric illness, and other neuropsychiatric sequelae including the emergence of acute Read more…

error: Content is protected !!